Hedef Girisim Sermayesi Cash Flow Conversion Efficiency
Hedef Girisim Sermayesi cash flow conversion efficiency. Based on the latest financial reports, Hedef Girisim Sermayesi (HDFGS) has a cash flow conversion efficiency ratio of -0.162x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL-437.02 Million ≈ $-9.79 Million USD) by net assets (TL2.70 Billion ≈ $60.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hedef Girisim Sermayesi (2014–2024)
Cash flow conversion efficiency of Hedef Girisim Sermayesi from 2014 to 2024. This chart illustrates how Hedef Girisim Sermayesi's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hedef Girisim Sermayesi (HDFGS) share price today for real-time trading data and today's change.
Hedef Girisim Sermayesi Cash Flow Conversion Ratio Explained
Hedef Girisim Sermayesi cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hedef Girisim Sermayesi Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hedef Girisim Sermayesi ranked by their cash flow conversion efficiency. Also see Hedef Girisim Sermayesi market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Derimod Konfeksiyon Ayakkabi Deri Sanayi ve Ticaret AS
IS:DERIM
|
1.189x |
|
ACCESS Newswire Inc.
NYSE MKT:ACCS
|
-0.019x |
|
Foodnamoo. Inc
KQ:290720
|
-0.175x |
|
Seach Medical Group Ltd
TA:SEMG
|
0.082x |
|
Bookook Steel
KO:026940
|
-0.006x |
|
Hoftex Group AG
MU:NBH
|
0.032x |
|
HI SPAC 3
KQ:217500
|
-0.025x |
|
Medicenna Therapeutics Corp
TO:MDNA
|
-0.799x |
Annual Cash Flow Conversion Efficiency for Hedef Girisim Sermayesi (2014–2024)
The table below shows the annual cash flow conversion efficiency of Hedef Girisim Sermayesi from 2014 to 2024. Review Hedef Girisim Sermayesi (HDFGS) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL2.14 Billion ≈ $47.87 Million |
TL632.77 Million ≈ $14.17 Million |
0.296x | -31.54% |
| 2023-12-31 | TL2.43 Billion ≈ $54.47 Million |
TL1.05 Billion ≈ $23.56 Million |
0.432x | +1075.76% |
| 2022-12-31 | TL1.18 Billion ≈ $26.35 Million |
TL-52.14 Million ≈ $-1.17 Million |
-0.044x | +79.47% |
| 2021-12-31 | TL511.78 Million ≈ $11.46 Million |
TL-110.51 Million ≈ $-2.48 Million |
-0.216x | -2272.40% |
| 2020-12-31 | TL393.65 Million ≈ $8.82 Million |
TL3.91 Million ≈ $87.64K |
0.010x | +125.84% |
| 2019-12-31 | TL134.09 Million ≈ $3.00 Million |
TL-5.16 Million ≈ $-115.51K |
-0.038x | +52.87% |
| 2018-12-31 | TL103.52 Million ≈ $2.32 Million |
TL-8.45 Million ≈ $-189.19K |
-0.082x | -220.12% |
| 2017-12-31 | TL70.22 Million ≈ $1.57 Million |
TL-1.79 Million ≈ $-40.09K |
-0.025x | -135.59% |
| 2016-12-31 | TL32.56 Million ≈ $729.37K |
TL2.33 Million ≈ $52.23K |
0.072x | +263.22% |
| 2015-12-31 | TL31.44 Million ≈ $704.17K |
TL-1.38 Million ≈ $-30.89K |
-0.044x | -258.29% |
| 2014-12-31 | TL24.11 Million ≈ $539.93K |
TL668.19K ≈ $14.97K |
0.028x | -- |
About Hedef Girisim Sermayesi
Hedef Girisim Sermayesi Yatirim Ortakligi A.S. is a venture capital and private equity firm specializing in seed/startup, middle market in growth capital companies. It prefers to invest in materials, industrials, consumer discretionary, financials, capital markets, insurance, information technology, communication services, SaaS, real sector, fintech, software, gaming, real estate, agriculture and… Read more